CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 164 enrolled
Drug / intervention
JUVÉDERM® VOLUMA® with Lidocaine +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03430986
NCT03430986N/ACompleted

A Randomized, Multicenter, "No-Treatment" Control Study to Evaluate the Safety and Effectiveness of JUVÉDERM® VOLUMA® With Lidocaine Injectable Gel for the Improvement of Volume and Aesthetic Appearance of the Nose in Chinese Adults

Allergan·interventional·Posted Feb 13, 2018·Updated Dec 30, 2020

In Brief

A clinical study evaluating JUVÉDERM® VOLUMA® with Lidocaine and No-treatment control for Nose Enhancement. Completed, enrolled 164 participants across 5 sites.

Detailed Summary

The purpose of this study is to determine whether VOLUMA with Lidocaine is safe and effective for the improvement of volume and aesthetic appearance of the nose in the Chinese population.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedFeb 13, 2018
Enrollment StartFeb 2, 2018
Primary CompletionDec 4, 2019
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 8.4 years ago

Interventions

JUVÉDERM® VOLUMA® with Lidocainedevice

Treatment with JUVÉDERM® VOLUMA® with Lidocaine injectable gel with optional treatment 8 weeks later.

No-treatment controlother

No treatment during the control period.